TW200500096A - Pharmaceutical solid preparation containing a poorly soluble drug and its production process - Google Patents

Pharmaceutical solid preparation containing a poorly soluble drug and its production process

Info

Publication number
TW200500096A
TW200500096A TW093113745A TW93113745A TW200500096A TW 200500096 A TW200500096 A TW 200500096A TW 093113745 A TW093113745 A TW 093113745A TW 93113745 A TW93113745 A TW 93113745A TW 200500096 A TW200500096 A TW 200500096A
Authority
TW
Taiwan
Prior art keywords
poorly soluble
soluble drug
solid preparation
organic solvents
preparation containing
Prior art date
Application number
TW093113745A
Other languages
English (en)
Inventor
Fumie Tanno
Yuichi Nishiyama
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of TW200500096A publication Critical patent/TW200500096A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1635—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for grafts, harvesting or transplants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/025—Pointed or sharp biopsy instruments for taking bone, bone marrow or cartilage samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1637—Hollow drills or saws producing a curved cut, e.g. cylindrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00477—Coupling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00969—Surgical instruments, devices or methods, e.g. tourniquets used for transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW093113745A 2003-05-16 2004-05-14 Pharmaceutical solid preparation containing a poorly soluble drug and its production process TW200500096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003138566A JP2004339162A (ja) 2003-05-16 2003-05-16 難溶性薬物を含む医薬用固形製剤とその製造方法

Publications (1)

Publication Number Publication Date
TW200500096A true TW200500096A (en) 2005-01-01

Family

ID=33028413

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093113745A TW200500096A (en) 2003-05-16 2004-05-14 Pharmaceutical solid preparation containing a poorly soluble drug and its production process

Country Status (6)

Country Link
US (1) US20040228916A1 (zh)
EP (1) EP1477161A1 (zh)
JP (1) JP2004339162A (zh)
KR (2) KR20040099158A (zh)
CN (1) CN100464738C (zh)
TW (1) TW200500096A (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
JP5124267B2 (ja) * 2005-02-25 2013-01-23 武田薬品工業株式会社 顆粒の製造方法
JP5159303B2 (ja) 2005-03-03 2013-03-06 武田薬品工業株式会社 放出制御組成物
TW200808380A (en) * 2006-02-21 2008-02-16 Shinetsu Chemical Co Enteric-coated preparation for site-specific delivery of drug to site within the small intestine
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8968456B2 (en) * 2009-08-28 2015-03-03 Hercules Incorporated Film coating composition from solid powder hydrophobic compounds
CN107951841B (zh) * 2017-12-21 2021-04-06 聊城大学 一种尼莫地平固体分散体及其片剂制备方法
JPWO2020045456A1 (ja) * 2018-08-28 2021-08-10 東和薬品株式会社 薬物含有粒子
KR20220030212A (ko) * 2019-04-25 2022-03-10 후지 파마 컴퍼니 리미티드 의약 제제 및 그 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139266A (ja) * 1983-01-28 1984-08-10 信越化学工業株式会社 腸溶性コ−テイング製剤の製造方法
US5789014A (en) * 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
EP0901786B1 (en) * 1997-08-11 2007-06-13 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
JP2000095709A (ja) * 1998-09-25 2000-04-04 Shin Etsu Chem Co Ltd 水系コーティング剤及び固形医薬製剤の製造方法
EP1297836A4 (en) * 2000-06-16 2007-06-13 Mitsubishi Pharma Corp COMPOSITIONS FOR CHECKING RELEASE, PH AREA AND / OR SPEED
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
EP2305219A1 (en) * 2000-11-17 2011-04-06 Takeda Pharmaceutical Company Limited Pharmaceutical preparations coated with a copolyvidone-containing coating
JP4644397B2 (ja) * 2001-09-05 2011-03-02 信越化学工業株式会社 難溶性薬物を含む医薬用固形製剤の製造方法

Also Published As

Publication number Publication date
JP2004339162A (ja) 2004-12-02
KR20080074083A (ko) 2008-08-12
CN100464738C (zh) 2009-03-04
KR20040099158A (ko) 2004-11-26
EP1477161A1 (en) 2004-11-17
CN1550230A (zh) 2004-12-01
US20040228916A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
TW200500096A (en) Pharmaceutical solid preparation containing a poorly soluble drug and its production process
WO2005117843A3 (en) Sustained release preparations
HUP0004050A2 (hu) Javított oldódású itrakonazol, eljárás ennek előállítására és ezt tartalmazó orális gyógyszerkészítmény
WO2007106182A3 (en) Process for making pharmaceutical compositions with a transient plasticizer
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
WO2010053335A2 (ko) 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에 의해 제조된 분말 및 이를 포함하는 약학적 조성물
ATE529098T1 (de) Feste arzneiform einer darmlöslichen dispersion und verfahren zur herstellung derselben
DE60305475D1 (de) Verfahren und vorrichtung zur herstellung von kapseln
GEP20115200B (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
MX2011006771A (es) Metodo de preparacion de una composicion de micelas polimericas que contienen un farmaco pobremente soluble en agua.
WO2008144365A3 (en) Method for making dry powder compositions containing ds-rna based on supercritical fluid technology
WO2004110979A3 (en) Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
ATE413875T1 (de) Zusammensetzungen enthaltend levetiracetam und verfahren zu deren herstellung.
AU2014251532B2 (en) Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
GEP20115186B (en) Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
WO2009007992A8 (en) Pharmaceutical composition produced by microprecipitation
TW200621307A (en) Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion
WO2022008627A3 (en) Improved method for the production of lysergic acid diethylamide (lsd) and novel derivatives thereof
PH12020550448A1 (en) Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same
ATE555776T1 (de) Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben
ATE258794T1 (de) Ein chinolonderivat enthaltendes arzneimittel und verfahren zu dessen herstellung
Bachu et al. Molecular iodine catalyzed transfer hydrogenation: reduction of aldimines, ketimines, and α-imino esters
Castagnino et al. Radical scavenging activity of 5-methylpyrrolidinone chitosan and dibutyryl chitin
WO2016126058A3 (ko) 두타스테라이드 함유 고체 분산체 및 이를 포함하는 조성물
MX2020001348A (es) Proceso para la disolución rápida de polvo que comprende polímero a base de acrilamida de bajo peso molecular.